+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share Price

₹30.26 +0.08 (0.27%)
34.70% Fall from 52W High

19 Oct, 2026 3:52 PM (IST)

Biofil Chemicals & Pharmaceuticals live price: ₹30.26. It opened at ₹31 vs previous close ₹30; intraday high/low: ₹31/₹30. The 50 & 200 DMA stand at ₹31.60/₹34.10.

Biofil Chemicals & Pharmaceuticals Performance

  • Today's Low
  • ₹30
  • Today's High
  • ₹31
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹46
  • Open Price₹31
  • Previous Close₹30
  • Volume17,528
  • 50 DMA₹31.60
  • 100 DMA₹32.40
  • 200 DMA₹34.10

Biofil Chemicals & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -7.83%
  • Over 3 Month -9.13%
  • Over 6 Month -12.11%
  • Over 1 Year -23.8%

Smart Investing Starts Here Start SIP with Biofil Chemicals & Pharmaceuticals for Steady Growth!

Invest Now

Biofil Chemicals & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 101.7
  • PEG Ratio
  • -1.2
  • Market Cap Cr
  • 49
  • P/B Ratio
  • 2.3
  • Average True Range
  • 1.5
  • EPS
  • 0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.6
  • RSI
  • 43.73
  • MFI
  • 45.78

Latest Stock News Updates

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended 30th September, 2026

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Closure of Trading Window

Intimation of closure of Trading window with effect from Thursday, 01st October 2026

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Change in Management

Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company , upon attaining the age of 75 (seventy-five) years.

Biofil Chemicals & Pharmaceuticals Financials

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹30.26
+ 0.08 (0.27%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹30.80
  • 50 Day
  • ₹31.60
  • 100 Day
  • ₹32.40
  • 200 Day
  • ₹34.10

Resistance and Support

30.39 Pivot Speed
  • R3 33.20
  • R2 32.30
  • R1 31.30
  • S1 29.40
  • S2 28.50
  • S3 27.50

Biofil Chemicals & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-11 Quarterly Results
2026-05-30 Audited Results
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results

Biofil Chemicals & Pharmaceuticals Shareholding Pattern

53.13%
46.79%
0.08%

About Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals manufactures formulations in the form of injectables, eye drops, and dry syrups. The Company offers products that include antibiotics, antianalgesics, diuretics, antimalarial vitamins, antacids, and anti-inflammatory the View More
  • NSE Symbol
  • BIOFILCHEM
  • BSE Symbol
  • 524396
  • ISIN
  • INE829A01014

Similar Stocks to Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals FAQs

Biofil Chemicals & Pharmaceuticals share price is ₹30 As on 21 October, 2026 | 01:43

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹49.2 Cr As on 21 October, 2026 | 01:43

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 101.7 As on 21 October, 2026 | 01:43

The PB ratio of Biofil Chemicals & Pharmaceuticals is 2.3 As on 21 October, 2026 | 01:43

The 52 week High & Low of Biofil Chemicals & Pharmaceuticals is ₹46.3/₹25.6 respectively As on 21 October, 2026 | 01:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23